Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Iradimed (IRMD) over the last 9 years, with Q4 2024 value amounting to $134580.0.

  • Iradimed's Treasury Shares fell 477.4% to $134580.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $134580.0, marking a year-over-year decrease of 477.4%. This contributed to the annual value of $134580.0 for FY2024, which is 477.4% down from last year.
  • Latest data reveals that Iradimed reported Treasury Shares of $1.8 million as of Q3 2017, which was down 8175.89% from $1.6 million recorded in Q2 2017.
  • Iradimed's Treasury Shares' 5-year high stood at $269609.0 during Q1 2020, with a 5-year trough of $131182.0 in Q4 2021.
  • Its 5-year average for Treasury Shares is $159933.2, with a median of $146491.5 in 2020.
  • The largest annual percentage gain for Iradimed's Treasury Shares in the last 5 years was 8175.89% (2017), contrasted with its biggest fall of 8442.05% (2017).
  • Iradimed's Treasury Shares (Quarter) stood at $10.0 million in 2016, then tumbled by 81.76% to $1.8 million in 2017.
  • Its Treasury Shares stands at $134580.0 for Q4 2024, versus $141327.0 for Q4 2023 and $151337.0 for Q4 2022.